Form 8-K - Current report:
SEC Accession No. 0001437749-25-000208
Filing Date
2025-01-03
Accepted
2025-01-03 16:02:58
Documents
18
Period of Report
2024-12-30
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 1.02: Termination of a Material Definitive Agreement
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 2.04: Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K veru20241220_8k.htm   iXBRL 8-K 41241
2 EXHIBIT 10.1 ex_761253.htm EX-10.1 541796
3 EXHIBIT 99.1 ex_761785.htm EX-99.1 18820
4 EXHIBIT 99.2 ex_759935.htm EX-99.2 347399
9 verusm.jpg GRAPHIC 13056
  Complete submission text file 0001437749-25-000208.txt   1235793

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA veru-20241230.xsd EX-101.SCH 3408
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE veru-20241230_def.xml EX-101.DEF 11423
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE veru-20241230_lab.xml EX-101.LAB 15309
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE veru-20241230_pre.xml EX-101.PRE 11583
20 EXTRACTED XBRL INSTANCE DOCUMENT veru20241220_8k_htm.xml XML 2819
Mailing Address 2916 N. MIAMI AVENUE SUITE 1000 MIAMI FL 33127
Business Address 2916 N. MIAMI AVENUE SUITE 1000 MIAMI FL 33127 3125959123
VERU INC. (Filer) CIK: 0000863894 (see all company filings)

EIN.: 391144397 | State of Incorp.: WI | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 001-13602 | Film No.: 25505881
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)